Study: New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications
MIAMI, FLORIDA (EMBARGOED UNTIL THURSDAY, NOV. 27, 2025) – In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival, protected vital organs, and promoted a balanced gut microbiome—offering hope for safer, more effective treatment of blood cancers. The study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborating organizations, is highlighted on the cover of the Nov. 27, 2025, issue of the journal, Blood.
The new protocol focuses on improving outcomes for patients who undergo allogeneic ...